Transenterix Stock Price, News & Analysis (NYSEAMERICAN:TRXC)

$2.49 -0.15 (-5.68 %)
(As of 11/17/2017 03:38 AM ET)
Previous Close$2.64
Today's Range$2.36 - $2.59
52-Week Range$0.45 - $5.00
Volume4.60 million shs
Average Volume3.24 million shs
Market Capitalization$535.96 million
P/E RatioN/A
Dividend YieldN/A

About Transenterix (NYSEAMERICAN:TRXC)

Transenterix logoTransEnterix, Inc. is a medical device company. The Company is focused on the development and commercialization of ALF-X Surgical Robotic System (the ALF-X System), and SurgiBot System. The Company's ALF-X System is a multi-port robotic surgery system, which allows multiple robotic arms to control instruments and a camera. The system features advanced technology to enable surgeons with haptic feedback and the ability to move the camera through eye movement. The system replicates laparoscopic motion and integrates three-dimensional high definition (3DHD) vision technology. The ALF-X System also offers responsible economics to hospitals by offering robotic technology with reusable instruments. The SurgiBot System is designed as a single-incision, patient-side robotic-assisted surgery system. The Company also develops and manufactures laparoscopic surgical instruments that are used in abdominal surgery, such as scissors, graspers, clip appliers, and suction and irrigation instruments.

Industry, Sector and Symbol:
  • Industry: Medical Equipment, Supplies & Distribution
  • Sub-Industry: N/A
  • Sector: Medical Equipment, Supplies & Distribution - NEC
  • CUSIP: N/A
  • Web:
  • Trailing EPS: ($0.62)
  • Net Margins: -928.85%
  • Return on Equity: -49.16%
  • Return on Assets: -33.51%
  • Outstanding Shares: 148,540,000

Frequently Asked Questions for Transenterix (NYSEAMERICAN:TRXC)

What is Transenterix's stock symbol?

Transenterix trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "TRXC."

How were Transenterix's earnings last quarter?

Transenterix Inc (NYSEAMERICAN:TRXC) issued its quarterly earnings results on Monday, March, 6th. The medical instruments supplier reported ($0.12) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.11) by $0.01. Transenterix had a negative net margin of 928.85% and a negative return on equity of 49.16%. View Transenterix's Earnings History.

Where is Transenterix's stock going? Where will Transenterix's stock price be in 2017?

3 analysts have issued 1 year target prices for Transenterix's shares. Their forecasts range from $0.70 to $5.00. On average, they anticipate Transenterix's stock price to reach $3.23 in the next twelve months. View Analyst Ratings for Transenterix.

Are investors shorting Transenterix?

Transenterix saw a increase in short interest during the month of October. As of October 31st, there was short interest totalling 9,857,271 shares, an increase of 16.2% from the October 13th total of 8,480,583 shares. Based on an average trading volume of 34,701,062 shares, the short-interest ratio is currently 0.3 days. Approximately 10.2% of the shares of the stock are short sold.

Who are some of Transenterix's key competitors?

Who are Transenterix's key executives?

Transenterix's management team includes the folowing people:

  • Paul A. LaViolette, Independent Chairman of the Board (Age 58)
  • Todd M. Pope, President, Chief Executive Officer, Director (Age 49)
  • Joseph P. Slattery CPA, Chief Financial Officer, Executive Vice President, IR Contact Officer (Age 50)
  • Anthony Fernando, Chief Operating Officer
  • Andrea Biffi, Director
  • Dennis J. Dougherty, Independent Director (Age 56)
  • Jane H. Hsiao Ph.D., Independent Director (Age 69)
  • William N. Kelley M.D., Independent Director (Age 77)
  • Aftab R. Kherani M.D., Independent Director (Age 41)

Who owns Transenterix stock?

Transenterix's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Ladenburg Thalmann Financial Services Inc. (0.05%). Company insiders that own Transenterix stock include Andrea Biffi, Anthony C J Fernando, Joseph P Slattery, Richard C Pfenniger Jr, SPA Sofar, Todd Pope and Willam N Kelley. View Institutional Ownership Trends for Transenterix.

Who bought Transenterix stock? Who is buying Transenterix stock?

Transenterix's stock was acquired by a variety of institutional investors in the last quarter, including Ladenburg Thalmann Financial Services Inc.. Company insiders that have bought Transenterix stock in the last two years include Andrea Biffi, Anthony C J Fernando, Joseph P Slattery, Richard C Pfenniger Jr, SPA Sofar and Willam N Kelley. View Insider Buying and Selling for Transenterix.

How do I buy Transenterix stock?

Shares of Transenterix can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Transenterix's stock price today?

One share of Transenterix stock can currently be purchased for approximately $2.49.

How big of a company is Transenterix?

Transenterix has a market capitalization of $535.96 million.

How can I contact Transenterix?

Transenterix's mailing address is 635 Davis Dr Ste 300, MORRISVILLE, NC 27560-7199, United States. The medical instruments supplier can be reached via phone at +1-919-7658400.

MarketBeat Community Rating for Transenterix (NYSEAMERICAN TRXC)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  121 (Vote Outperform)
Underperform Votes:  105 (Vote Underperform)
Total Votes:  226
MarketBeat's community ratings are surveys of what our community members think about Transenterix and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for Transenterix (NYSEAMERICAN:TRXC)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 1 Hold Rating, 2 Buy Ratings, 0 Strong Buy Ratings
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $3.23

Consensus Price Target History for Transenterix (NYSEAMERICAN:TRXC)

Price Target History for Transenterix (NYSEAMERICAN:TRXC)

Analysts' Ratings History for Transenterix (NYSEAMERICAN:TRXC)

DateFirmActionRatingPrice TargetDetails
10/31/2017Stifel NicolausBoost Price TargetBuy$3.75 -> $4.00View Rating Details
10/20/2017Ladenburg Thalmann Financial ServicesSet Price TargetBuy$5.00View Rating Details
5/16/2017B. RileyDowngradeNeutral$0.70View Rating Details
1/19/2017Raymond James Financial, Inc.DowngradeOutperform -> Mkt PerformView Rating Details
5/16/2016Sterne Agee CRTReiterated RatingBuyView Rating Details
5/11/2016Lake Street CapitalDowngradeBuy -> Hold$2.00View Rating Details
4/18/2016BTIG ResearchDowngradeBuy -> Neutral$6.00View Rating Details
(Data available from 11/18/2015 forward)


Earnings History and Estimates Chart for Transenterix (NYSEAMERICAN:TRXC)

Earnings by Quarter for Transenterix (NYSEAMERICAN:TRXC)

Earnings History by Quarter for Transenterix (NYSEAMERICAN TRXC)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/6/2017Q4 2016($0.11)($0.12)ViewListenView Earnings Details
11/9/2016Q316($0.10)($0.11)$1.80 million$1.50 millionViewListenView Earnings Details
5/10/2016Q116($0.13)($0.12)ViewListenView Earnings Details
3/3/2016Q415($0.12)($0.13)ViewN/AView Earnings Details
8/6/2015Q215($0.15)($0.14)ViewN/AView Earnings Details
5/6/2015Q115($0.17)($0.16)$0.03 millionViewN/AView Earnings Details
2/24/2015Q414($0.18)($0.13)$50.00 million$0.13 millionViewN/AView Earnings Details
11/6/2014Q3($0.18)($0.18)$0.10 million$0.06 millionViewN/AView Earnings Details
5/7/2014($0.14)($0.15)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Transenterix (NYSEAMERICAN:TRXC)

No earnings estimates for this company have been tracked by


Dividend History for Transenterix (NYSEAMERICAN:TRXC)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for Transenterix (NYSEAMERICAN TRXC)

Insider Trades by Quarter for Transenterix (NYSEAMERICAN:TRXC)

Insider Trades by Quarter for Transenterix (NYSEAMERICAN TRXC)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/16/2017Joseph P SlatteryCFOSell529,609$2.80$1,482,905.20View SEC Filing  
11/14/2017Joseph P SlatteryCFOSell333,000$2.93$975,690.00View SEC Filing  
10/18/2017Todd PopeInsiderSell600,000$3.68$2,208,000.00View SEC Filing  
8/8/2017Willam N KelleyDirectorBuy30,000$0.71$21,300.00View SEC Filing  
5/16/2017Richard C Pfenniger JrDirectorBuy100,000$0.54$54,000.00View SEC Filing  
1/4/2017S.P.A SofarMajor ShareholderBuy3,722,685$1.40$5,211,759.00View SEC Filing  
8/22/2016Andrea BiffiDirectorBuy40,000$1.40$56,000.00View SEC Filing  
6/14/2016Anthony C J FernandoCTOBuy27,000$1.46$39,420.00View SEC Filing  
5/13/2016Joseph P SlatteryCFOBuy50,000$1.92$96,000.00View SEC Filing  
11/16/2015Andrea BiffiDirectorBuy25,000$2.81$70,250.00View SEC Filing  
11/13/2015Willam N KelleyDirectorBuy20,000$2.80$56,000.00View SEC Filing  
11/12/2015Joseph P SlatteryCFOBuy15,000$2.77$41,550.00View SEC Filing  
10/2/2014Joseph P SlatteryCFOSell33,000$4.19$138,270.00View SEC Filing  
9/8/2014Richard MuellerCOOSell3,000$3.60$10,800.00View SEC Filing  
9/8/2014Todd PopeCEOSell50,000$3.70$185,000.00View SEC Filing  
4/21/2014Aisling Capital Iii LpMajor ShareholderBuy1,037,767$4.00$4,151,068.00View SEC Filing  
4/21/2014William N Starling JrDirectorBuy221,450$4.00$885,800.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Transenterix (NYSEAMERICAN:TRXC)

Latest Headlines for Transenterix (NYSEAMERICAN TRXC)

Transenterix Inc (TRXC) CFO Joseph P. Slattery Sells 529,609 SharesTransenterix Inc (TRXC) CFO Joseph P. Slattery Sells 529,609 Shares - November 16 at 10:36 PM
Transenterix Inc (TRXC) CFO Joseph P. Slattery Sells 333,000 SharesTransenterix Inc (TRXC) CFO Joseph P. Slattery Sells 333,000 Shares - November 16 at 10:33 PM

Social Media

Social activity is not available for this stock.



Transenterix (NYSEAMERICAN TRXC) Chart for Saturday, November, 18, 2017
Loading chart…

This page was last updated on 11/18/2017 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.